Impact of Preimmunization on Adenoviral Vector Expression and Toxicity in a Subcutaneous Mouse Cancer Model

Author： Vlachaki M.T.   Hernandez-Garcia A.   Ittmann M.   Chhikara M.   Aguilar L.K.   Zhu X.   The B.S.   Butler E.B.   Woo S.   Thompson T.C.   Barrera-Saldana H.   Aguilar-Cordova E.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.6, Iss.3, 2002-09, pp. : 342-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenoviral Vector-Based Strategies for Cancer Therapy

By  

Current Drug Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 117-138

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Delivery of a High-Capacity Adenoviral Vector Expressing Mouse CTLA4Ig Improves Skeletal Muscle Gene Therapy

By Jiang Z.   Feingold E.   Kochanek S.   Clemens P.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 369-376

Elsevier

Access to resources Recommend Favorite

Dual Targeting of Adenoviral Vectors at the Levels of Transduction and Transcription Enhances the Specificity of Gene Expression in Cancer Cells

By Barnett B.G.   Tillman B.W.   Curiel D.T.   Douglas J.T.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Improved system for helper-dependent adenoviral vector production

By Palmer D.   Ng P.  

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 846-852

Elsevier

Access to resources Recommend Favorite

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

By Fu H.   Muenzer J.   Samulski R.J.   Breese G.   Sifford J.   Zeng X.   McCarty D.M.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 911-917

Elsevier

Access to resources Recommend Favorite